The antioxidative effect of carboxyfullerenes (C3/D3) on iron-induced oxidative injury in CNS

Annals of the New York Academy of Sciences

Volumn 890, Issue , 1999, Pages 340-351

  Lin, Anya M Y ^a   Luh, T Y ^b   Chou, C K ^a   Ho, L T ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFULLERENE; DOPAMINE; FULLERENE DERIVATIVE; GLUTATHIONE; IRON; POTASSIUM ION; TROLOX C; UNCLASSIFIED DRUG; URETHAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AUTOOXIDATION; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; LIPID PEROXIDATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALIA;

EID: 0033403164     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08012.x     Document Type: Conference Paper

References (42)

1. 60: Buckminsterfullerene. Nature 318: 162-163.
2. 60: a new form of carbon. Nature 347: 354-358.
3. 3. Dugan, L.L., J.K. Gabrielesen, S.P. Yu, T.S. Lin & D.W. Choi. 1996. Buckminster-fullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 3: 129-135.
4. 4. Dugan, L.L., D.M. Turetsky, C. Du, D. Lobner, M. Wheeler, C.R. Almli, C.K. Shen, T.Y. Luh, D.W. Choi & T.S. Lin. 1997. Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. USA 94: 9434-9439.
5. 5. Lai, Y.L. & L.Y. Chiang. 1997. Water-soluble fullerene derivatives attenuate exsanguination-induced bronchoconstriction of guinea-pigs. J. Auton. Pharmacol. 17: 229-235.
6. 60, fullerenol, a novel free radical trapper, prevented hydrogen peroxide-and cumene hydroperoxide-elicited changes in rat hippocampus in vitro. J. Pharm. Pharmacol. 49: 438-445.
7. 7. Halliwell, B. & J.M. Gutteridge. 1984. Oxygen toxicity, oxygen radicals, transition metals and diseases. Biochem. J. 219: 1-14.
8. 8. Perry, T.L., D.V. Godin & A. Hansen. 1982. Parkinson's disease: a disorder due to nigral glutathione deficiency. Neurosci. Lett. 33: 305-310.
9. 9. Sofic, E., K.W. Lange, K. Jellinger & P. Riederer. 1992. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142: 128-130.
10. 10. Youdim, M.B., D. Ben-Shachar, G. Eshel, J.P.M. Finberg & P. Riederer. 1993. The neurotoxicity of iron and nitric oxide relevance to the etiology of Parkinson's disease. In Advances in Neurology. H. Narabyashi, T. Nagatsu, N. Yanagisawa & Y. Mizuno, Eds.: 259-266. Raven Press. New York.
11. 11. De La Torre, M.R., A. Casado, M.E. Lopez-Fernandez, D. Carrascosa, M.C. Casado, D. Venarucci & V. Venarucci. 1996. Human aging brain disorders: role of antioxidant enzymes. Neurochem. Res. 21: 885-888.
12. 12. Sofic, E., W. Paulus, K. Jellinger, P. Riederer & M.B.H. Youdim. 1991. Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains. J. Neurochem. 56: 978-982.
13. 13. Dexter, D.T., F.R. Wells, A.J. Lees, F. Agid, Y. Agid, P. Jenner & C.D. Marsden. 1989. Increased nigral iron content and alteration in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52: 1830-1836.
14. 14. Halliwell, B. 1992. Reactive oxygen species and the central nervous system. J. Neurochem. 59: 1609-1623.
15. 15. Ames, B.N., M.K. Shigenaga & T.M. Hagen. 1993. Oxidants, antioxidants and the degenerative disease of aging. Proc. Natl. Acad. Sci. USA 90: 7915-7922.
16. 16. Cohen, G. & P. Werner. 1994. Free radicals, oxidative stress and neurodegeneration. In Neurodegenerative Diseases. D.B. Calne, Ed.: 139-162. W.B. Saunders. Philadelphia.
17. 17. Jenner, P. & C.W. Olanow. 1996. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47: S161-S170.
18. 18. Hirsch, E.C. 1993. Does oxidative stress participate in nerve cell death in Parkinson's disease. Eur. Neurol. 33 (Suppl. 1): 52-59.
19. 19. Ebadi, M., S.K. Srinivasan & M.D. Baxi. 1996. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48:1-19.
20. 20. Ben-Shachar, D. & M.B.H. Youdim. 1991. Intranigral iron injection induced behavioral and biochemical "Parkinsonism" in rats. J. Neurochem. 57: 2133-2135.
21. 21. Sengstock, G.J., C.W. Olanow, A.J. Dunn, S. Barone, Jr. & G.W. Arendash. 1994. Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra. J. Exp. Neurol. 130: 82-94.
22. 22. Rauhala, P., K.P. Mohanakumar, I. Sziraki, A.M.Y. Lin & C.C. Chiueh. 1996. S-Nitrosothiols and nitric oxide, but not sodium nitroprusside protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23: 58-60.
23. 23. Rauhala, P., A.M.Y. Lin & C.C. Chiueh. 1998. Neuroprotection by S-nitroso glutathione of brain dopamine neurons from oxidative stress. FASEB J. 12: 165-173.
24. 24. Lin, A.M.Y., C.H. Yang & C.Y. Chai. 1998. Striatal dopamine dynamics are altered following an intranigral infusion of iron in SD rat. Free Radical Biol. Med. 24: 988-993.
25. 25. Lin, A.M.Y., B.Y. Chyi, S.D. Wang, H.-H. Yu, P.P. Kanakamma, T.-Y. Lun, C.K. Chou & L.T. Ho. 1999. Carboxyfullerene prevents iron-induced oxidative stress in rat brain. J. Neurochem. 72: 1634-1640.
26. 26. Paxinos, G. & C. Watson. 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press. New York.
27. 27. Friedemann, M.N. 1992. In vivo electrochemical studies of dopamine diffusion and clearance in the striatum of young and aged F344 rats. Age 15: 23-28.
28. 28. Gerhardt, G.A., A.F. Oke, G. Nagy, B. Moghaddam & R.N. Adams. 1984. Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 290: 390-395.
29. 29. Su, M.T., T.V. Dunwiddie, M. Mynlieff & G.A. Gerhardt. 1990. Electrochemical characterization of stimulated norepinephrine overflow in locus coeruleus-hippocampus double brain grafts grown in oculo. Neurosci. Lett. 110: 186-192.
30. 30. Gerhardt, G.A. & M. Palmer. 1987. Characterization of the techniques of pressure ejection and microiontophoresis using in vivo electrochemistry. J. Neurosci. Methods 22: 147-159.
31. 31. Kikugawa, K., T. Kato, M. Beppu & A. Haysaaka. 1989. Fluorescent and crosslinked protein formed by free radical and aldehyde species generated during lipid peroxidation. Adv. Exp. Med. Biol. 266: 345-356.
32. 32. Mokanakumar, K.P., A. DeBartolomeis, R.M. Wu, K.J. Yeh, L.M. Sternberger, S. Peng, D.L. Murphy & C.C. Chiueh. 1994. Ferrous citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation. Ann. N.Y. Acad. Sci. 738: 392-399.
33. 33. Reiter, R., L. Tang, J.J. Garcia & A. Munoz-Hoyos. 1997. Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60: 2255-2271.
34. 60 by photoacoustic calorimetry. J. Phys. Chem. 95: 6073-6075.
35. 35. Krasnovsky, JR., A.A. & C.S. Foote. 1993. Time-resolved measurements of singlet oxygen dimol-sensitized luminescence. J. Am. Chem. Soc. 115: 6013-6016.
36. 60 with other photosensitizer, based on 1268 nm emission. Chem. Pharm. Bull. 42: 2291-2294.
37. 60, on nitric-oxide-induced relaxation of rabbit aorta. Eur. J. Pharmacol. 327: 175-181.
38. 38. Tsuchiya, T., I. Oguri, Y.N. Yamakoshi & N. Miyata. 1996. Novel harmful effects of [60] fullerene on mouse embryos in vitro and in vivo. FEBS Lett. 393: 139-145.
39. 60 in rats. Toxicol. Pathol. 26: 143-151.
40. 60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogensis 17: 2163-2169.
41. 41. Hou, J.G., G. Cohen & C. Mytilineou. 1997. Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-OHDA toxicity: involvement of the glutathione system. J. Neurochem. 69: 76-83.
42. 42. Furukawa, K., S. Estus, W. Fu, R.J. Mark & M.P. Mattson. 1997. Neuroprotective action of cycloheximide involves induction of bcl-2 and antioxidant pathways. J. Cell Biol. 136: 1137-1149.